Anterix
ATEX
129 hedge funds and large institutions have $594M invested in Anterix in 2024 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 43 increasing their positions, 38 reducing their positions, and 12 closing their positions.
998% more call options, than puts
Call options by funds: $1.2M | Put options by funds: $109K
117% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 12
13% more repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 38
12% more funds holding
Funds holding: 115 → 129 (+14)
4.06% more ownership
Funds ownership: 80.7% → 84.76% (+4.1%)
0% more capital invested
Capital invested by funds: $593M → $594M (+$404K)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
+$7.63M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.23M |
| 3 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$5.98M |
| 4 |
Nuveen
Charlotte,
North Carolina
|
+$4.34M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$4.19M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$4.42M |
| 2 |
SCM
Stonehill Capital Management
New York
|
-$4.42M |
| 3 |
RC
Roubaix Capital
Denver,
Colorado
|
-$2.68M |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
-$2.23M |
| 5 |
2C
272 Capital
Dallas,
Texas
|
-$2.07M |
ATEX Hedge Fund Activity: Q3 2024 in Review
129 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Anterix (ATEX) for Q3 2024, worth a combined $594M — up 0.07% from $593M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new ATEX positions and 12 closed out — a net gain of 14 holders — while 43 added to existing stakes and 38 trimmed.
The largest buyer was D.E. Shaw & Co, adding an estimated $7.63M. The largest seller was BlackRock, cutting an estimated $4.42M.
- 129 institutional investors held Anterix (ATEX) as of Q3 2024, up from 115 in Q2 2024.
- Funds reported $594M of Anterix stock for Q3 2024, up 0.07% quarter-over-quarter.
- 26 funds opened new Anterix positions in Q3 2024 and 12 closed out, a net change of +14 holders.
- The largest Anterix buyer in Q3 2024 was D.E. Shaw & Co, an estimated $7.63M added.
- The largest Anterix seller in Q3 2024 was BlackRock, an estimated $4.42M sold.
Based on aggregated 13F filings for Q3 2024.